Royal Bank of Canada’s Park Ha Biological Technology Co BYAH Stock Holding History

Royal Bank of Canada’s Portfolio BYAH Stock Details BYAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Hold	0	–	–	–	7798
2025 Q4	–	Hold	0	–	–	–	7750
2025 Q3	–	Hold	0	–	–	–	7612
2025 Q2	–	Sell	-6	Closed	-$40.3K	–	6954
2025 Q1	$30K	Buy	+6	New	+$16.3K	﹤0.01%	5781

Other funds holding BYAH

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada's BYAH Position: Q1 2026 in Review

Royal Bank of Canada held its Park Ha Biological Technology Co (BYAH) position steady in Q1 2026 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7798.

Royal Bank of Canada first reported a position in BYAH in Q1 2025 and has held it in 1 quarter since. The position peaked at $30K in Q1 2025. 2 funds tracked by Wall St. Rank hold BYAH as of Q1 2026.

Royal Bank of Canada held 0 shares of Park Ha Biological Technology Co worth $0 as of Q1 2026.
Royal Bank of Canada left its Park Ha Biological Technology Co share count unchanged in Q1 2026.
Park Ha Biological Technology Co made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7798 holding.
Royal Bank of Canada first reported a position in Park Ha Biological Technology Co in Q1 2025 and has held it in 1 quarter since.
Royal Bank of Canada's Park Ha Biological Technology Co position peaked at $30K in Q1 2025.
2 funds tracked by Wall St. Rank held Park Ha Biological Technology Co as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.